Schedule 13G ownership disclosure

Dyne Therapeutics Inc

Common Stock · CUSIP: 26818M108

Event date: 2025-03-31

Filing-level shares
10,353,875
Percent of class
9.2%
  • JANUS HENDERSON GROUP PLC

    Shares: 10,353,875 · Class: 9.2%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001274173-25-000144
Form type
SCHEDULE 13G/A
Filer
Dyne Therapeutics, Inc.
CIK
CIK 1818794
Filed
May 14, 2025
Reporting period
Mar 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub